IL257622B
(en )
2019-12-31
Methods and preparations for the treatment of persistent infections
BRPI0720124A2
(en )
2014-03-04
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
IL188732A
(en )
2014-07-31
Use of ibuprofen and pamotidine for drug preparation
ATE482618T1
(en )
2010-10-15
ACTIVE INGREDIENTS COMBINATIONS
CY2017018I2
(en )
2017-11-14
PREPARATION OF ACTIVE, HIGHLY PHOSPHORYLATED, HUMAN LYSOSOMIC SULFATASE ENZYMES AND USES THEREOF
ATE553096T1
(en )
2012-04-15
PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC ACTIVE INGREDIENTS
IL243534A0
(en )
2016-02-29
Methods for the preparation of biologically active compounds in the form of nanoparticles
FI20051318A0
(en )
2005-12-22
Treatment of cellulosic material and the enzymes used
ATE484194T1
(en )
2010-10-15
ACTIVE INGREDIENTS COMBINATIONS
EP1891597A4
(en )
2012-12-12
UNITED ADMINISTRATION OF ADMINISTRATION, ADMINISTRATION AND ILLUSTRATION OF RADIOPHARMACEUTICS
IL191759A
(en )
2015-05-31
Genaxolone preparations and methods for their preparation and use
EP1854160A4
(en )
2015-11-25
ACTIVE REDOX STRUCTURES AND DEVICES USING THE SAME
CR9878A
(en )
2008-07-29
TREATMENT AND PROPHYLAXIS OF MICROANGIOPATIAS
PL1954684T3
(en )
2014-10-31
Oxazole Compound and Pharmaceutical Composition
HRP20160866T1
(en )
2016-10-07
METHODS OF ADMINISTRATION OF HYPOGLYCEMIC AGENTS
CR9850A
(en )
2008-06-18
CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
CY1117174T1
(en )
2017-04-05
USE OF 24-norUDCA FOR TREATMENT OF US CHOLOGICAL DISEASES
BRPI0813587A2
(en )
2014-12-30
COMPOUND, USE OF THE SAME, AND PHARMACEUTICAL COMPOSITION
BRPI0818121A2
(en )
2015-11-17
diespiro 1,2,4-trioxolane and its methods of manufacture and use
BRPI0720323A2
(en )
2016-08-09
compound, method of treatment, pharmaceutical composition and use of the compound
IL187121A
(en )
2013-06-27
Preparations for reducing residues that have been engraved and ash residues of light active substance and light active substance
CL2007002769A1
(en )
2008-07-04
COMPOUNDS DERIVED FROM SULFONAMIDE; OBTAINING PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DIABETES.
PL1948358T3
(en )
2012-06-29
Application of the catalyst composition and the method of oxychlorination
IL181819A
(en )
2013-07-31
Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds
NO20055643D0
(en )
2005-11-29
Preparation of lodixanol